KINE-101B

N/A

Report date: 2025/02/27 16:55:03
NME

Base Information

Drug NameKINE-101B
Drug Alias NameKINE-101B
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionRegulatory T-lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKine Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKine Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A